MedPath

The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients

Phase 3
Completed
Conditions
Mycobacterium Avium-intracellulare Infection
HIV Infections
Registration Number
NCT00001030
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To compare the efficacy and safety of clarithromycin alone versus rifabutin alone versus the two drugs in combination for the prevention or delay of Mycobacterium avium Complex (MAC) bacteremia or disseminated MAC disease. To compare other parameters such as survival, toxicity, and quality of life among the three treatment arms. To obtain information on the incidence and clinical grade of targeted gynecologic conditions.

Persons with advanced stages of HIV are considered to be at particular risk for developing disseminated MAC disease. The development of an effective regimen for the prevention of disseminated MAC disease may be of substantial benefit in altering the morbidity and possibly the mortality associated with this disease and its treatment.

Detailed Description

Persons with advanced stages of HIV are considered to be at particular risk for developing disseminated MAC disease. The development of an effective regimen for the prevention of disseminated MAC disease may be of substantial benefit in altering the morbidity and possibly the mortality associated with this disease and its treatment.

Patients are randomized to receive clarithromycin alone, rifabutin alone, or the two drugs in combination daily. Patients are evaluated every 4 weeks for the first 8 weeks and every 8 weeks thereafter for the duration of the study. Patients are followed for 24 months. Per amendment, a pharmacokinetic substudy will be conducted.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (42)

Cook County Hosp. CORE Ctr.

🇺🇸

Chicago, Illinois, United States

Rush Univ. Med. Ctr. ACTG CRS

🇺🇸

Chicago, Illinois, United States

Univ. of Miami AIDS CRS

🇺🇸

Miami, Florida, United States

Alabama Therapeutics CRS

🇺🇸

Birmingham, Alabama, United States

UCLA CARE Center CRS

🇺🇸

Los Angeles, California, United States

Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.

🇺🇸

Oakland, California, United States

Ucsf Aids Crs

🇺🇸

San Francisco, California, United States

Howard University Hosp., Div. of Infectious Diseases, ACTU

🇺🇸

Washington, District of Columbia, United States

Chicago Children's CRS

🇺🇸

Chicago, Illinois, United States

Univ. of Hawaii at Manoa, Leahi Hosp.

🇺🇸

Honolulu, Hawaii, United States

Northwestern University CRS

🇺🇸

Chicago, Illinois, United States

Indiana Univ. School of Medicine, Infectious Disease Research Clinic

🇺🇸

Indianapolis, Indiana, United States

Methodist Hosp. of Indiana

🇺🇸

Indianapolis, Indiana, United States

Univ. of Iowa Healthcare, Div. of Infectious Diseases

🇺🇸

Iowa City, Iowa, United States

Massachusetts General Hospital ACTG CRS

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess - East Campus A0102 CRS

🇺🇸

Boston, Massachusetts, United States

Bmc Actg Crs

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Med. Ctr., ACTG CRS

🇺🇸

Boston, Massachusetts, United States

University of Minnesota, ACTU

🇺🇸

Minneapolis, Minnesota, United States

Washington U CRS

🇺🇸

Saint Louis, Missouri, United States

St. Louis ConnectCare, Infectious Diseases Clinic

🇺🇸

Saint Louis, Missouri, United States

Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.

🇺🇸

Omaha, Nebraska, United States

Bronx-Lebanon Hosp. IMPAACT CRS

🇺🇸

Bronx, New York, United States

SUNY - Buffalo, Erie County Medical Ctr.

🇺🇸

Buffalo, New York, United States

NY Univ. HIV/AIDS CRS

🇺🇸

New York, New York, United States

Memorial Sloan-Kettering Cancer Ctr.

🇺🇸

New York, New York, United States

Beth Israel Med. Ctr. (Mt. Sinai)

🇺🇸

New York, New York, United States

Cornell University A2201

🇺🇸

New York, New York, United States

Univ. of Rochester ACTG CRS

🇺🇸

Rochester, New York, United States

Unc Aids Crs

🇺🇸

Chapel Hill, North Carolina, United States

Carolinas HealthCare System, Carolinas Med. Ctr.

🇺🇸

Charlotte, North Carolina, United States

Regional Center for Infectious Disease, Wendover Medical Center CRS

🇺🇸

Greensboro, North Carolina, United States

Case CRS

🇺🇸

Cleveland, Ohio, United States

MetroHealth CRS

🇺🇸

Cleveland, Ohio, United States

The Ohio State Univ. AIDS CRS

🇺🇸

Columbus, Ohio, United States

The Children's Hosp. of Philadelphia IMPAACT CRS

🇺🇸

Philadelphia, Pennsylvania, United States

Hosp. of the Univ. of Pennsylvania CRS

🇺🇸

Philadelphia, Pennsylvania, United States

University of Washington AIDS CRS

🇺🇸

Seattle, Washington, United States

Mbeya Med. Research Program, Mbeya Referral Hosp. CRS

🇹🇿

Mbeya, Tanzania

Univ. of Cincinnati CRS

🇺🇸

Cincinnati, Ohio, United States

Hennepin County Med. Ctr., Div. of Infectious Diseases

🇺🇸

Minneapolis, Minnesota, United States

Johns Hopkins Adult AIDS CRS

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath